These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33099748)

  • 1. Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications.
    Wang D; Sun L; Zhang G; Liu Y; Liang Z; Zhao J; Yin S; Su M; Zhang S; Wei Y; Liu H; Liang D; Li Y
    Cardiovasc Toxicol; 2021 Mar; 21(3):192-205. PubMed ID: 33099748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model.
    Wu Q; Liu H; Liao J; Zhao N; Tse G; Han B; Chen L; Huang Z; Du Y
    Biomed Pharmacother; 2020 Sep; 129():110384. PubMed ID: 32554248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties.
    Ma J; Ma S; Yin C; Wu H
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):616-627. PubMed ID: 29377366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and its arrhythmogenesis associated with insulin resistance.
    Chan YH; Chang GJ; Lai YJ; Chen WJ; Chang SH; Hung LM; Kuo CT; Yeh YH
    Cardiovasc Diabetol; 2019 Sep; 18(1):125. PubMed ID: 31558158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
    Chen CC; Hsu YJ; Lee TM
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1107-17. PubMed ID: 21622823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
    Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
    Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Salt Diet Inhibits the Expression of Bmal1 and Promotes Atrial Fibrosis and Vulnerability to Atrial Fibrillation in Dahl Salt-Sensitive Rats.
    Wang XH; Zhang ZZ; Ou Y; Ning ZH; Yang JY; Huang H; Tang HF; Jiang ZS; Hu HJ
    Am J Hypertens; 2024 Aug; 37(9):726-733. PubMed ID: 38761040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of natriuretic peptide clearance receptor attenuates TGF-β1-induced selective atrial fibrosis and atrial fibrillation.
    Rahmutula D; Zhang H; Wilson EE; Olgin JE
    Cardiovasc Res; 2019 Feb; 115(2):357-372. PubMed ID: 30239604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits.
    Fu H; Li G; Liu C; Li J; Wang X; Cheng L; Liu T
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):211-22. PubMed ID: 25199622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats.
    Zhang K; Ma Z; Wang W; Liu R; Zhang Y; Yuan M; Li G
    Cardiovasc Ther; 2018 Dec; 36(6):e12466. PubMed ID: 30203914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia and Atrial Fibrillation.
    Maharani N; Kuwabara M; Hisatome I
    Int Heart J; 2016 Jul; 57(4):395-9. PubMed ID: 27396561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure.
    Qiu H; Wu H; Ma J; Cao H; Huang L; Qiu W; Peng Y; Ding C
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):323-334. PubMed ID: 29290021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.
    Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice.
    Scholz B; Schulte JS; Hamer S; Himmler K; Pluteanu F; Seidl MD; Stein J; Wardelmann E; Hammer E; Völker U; Müller FU
    Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007071. PubMed ID: 30879335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post-Myocardial Infarction Rats.
    Liu M; Li W; Wang H; Yin L; Ye B; Tang Y; Huang C
    J Am Heart Assoc; 2019 Nov; 8(21):e013133. PubMed ID: 31623508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease.
    Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H
    Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-Gallate Inhibits Atrial Fibrosis and Reduces the Occurrence and Maintenance of Atrial Fibrillation and its Possible Mechanisms.
    Li T; Tong Q; Wang Z; Yang Z; Sun Y; Cai J; Xu Q; Lu Y; Liu X; Lin K; Qian Y
    Cardiovasc Drugs Ther; 2024 Oct; 38(5):895-916. PubMed ID: 37000367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑101a‑3p overexpression prevents acetylcholine‑CaCl
    Zhu J; Zhu N; Xu J
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34435649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
    Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
    Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
    J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.